We are live on
!
Find out more
NMVA
New Mountain Vantage Advisers Portfolio holdings
AUM
$4.33B
1-Year Est. Return
35.3%
This Fund
S&P 500
This Quarter
Est. Return
+7.53%
1 Year Est. Return
-35.3%
3 Year Est. Return
+2.05%
5 Year Est. Return
+37.91%
10 Year Est. Return
–
AUM
$5.44B
AUM Growth
+$387M
(+7.7%)
Cap. Flow
+$29M
Cap. Flow
% of AUM
0.53%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
11
New
–
Increased
5
Reduced
2
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LSXMA
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
|
+$10M |
| 2 |
FISV
Fiserv Inc
FISV
|
+$9.92M |
| 3 |
Comcast
CMCSA
|
+$4.8M |
| 4 |
Fidelity National Information Services
FIS
|
+$4.54M |
| 5 |
Liberty Broadband Class C
LBRDK
|
+$2.98M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BLPH
Bellerophon Therapeutics, Inc.
BLPH
|
+$1.31M |
| 2 |
LKQ Corp
LKQ
|
+$47K |
| 3 |
CIT
CIT Group Inc.
CIT
|
+$37.8K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 96.32% |
| 2 | Consumer Discretionary | 1.16% |
| 3 | Technology | 0.94% |
| 4 | Communication Services | 0.8% |
| 5 | Financials | 0.25% |
Similar funds
NA
SPF
RE
AP
AWM
FWM
BDWM
DHFB
New Mountain Vantage Advisers's Q2 2021 Portfolio in Review
As of Q2 2021, New Mountain Vantage Advisers held 11 positions worth $5.44B, up 7.7% from $5.06B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
New Mountain Vantage Advisers's Q2 2021 filing shows 5 increased, 2 reduced and 2 closed positions. The largest sale was Bellerophon Therapeutics, Inc., an estimated $1.31M.
By sector, the portfolio is most concentrated in Healthcare at 96% of assets, down from 97% a quarter earlier, followed by Consumer Discretionary and Technology.
- New Mountain Vantage Advisers added most to Liberty Media Corporation Series A Liberty SiriusXM Common Stock in Q2 2021, an estimated $10M increase.
- New Mountain Vantage Advisers's biggest Q2 2021 reduction was LKQ Corp, cutting an estimated $47K.
- New Mountain Vantage Advisers fully exited Bellerophon Therapeutics, Inc. in Q2 2021, selling an estimated $1.31M.
- New Mountain Vantage Advisers's ten largest holdings make up 100% of its $5.44B portfolio in Q2 2021.
- New Mountain Vantage Advisers opened 0 new positions and closed 2 in Q2 2021.
- New Mountain Vantage Advisers's portfolio value rose 7.7% quarter-over-quarter to $5.44B.
Based on New Mountain Vantage Advisers's 13F filing for Q2 2021, filed 16 Aug 2021.